Harry Werner Kirsch holds the position of Chief Financial Officer of Novartis AG. Mr. Kirsch is also on the board of Novartis International AG, Novartis Vaccines & Diagnostics, Inc., Novartis Institutes for Biomedical Research, Inc. and Novartis Pharma KK.

In his past career he occupied the position of CFO-Global Pharmaceutical Business at Procter & Gamble Co.

He received an undergraduate degree from Karlsruher Institut für Technologie.